Get started
Author

Ken Ishiyama

Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO 'MDS-U' designation
2012 · K. Hosokawa, T. Katagiri, et al. · Haematologica · 69
PDF
Safety of pre‐engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation
2011 · K. Ishiyama, T. Katagiri, et al. · Transplant Infectious Disease · 49
HLA Class I Allele-Specific Pathology Defines Clinical Manifestations of Immune Aplastic Anemia
2022 · Yoshitaka Zaimoku, Hiroki Mizumaki, et al. · Blood · 3
Prognostic Relevance of Integrated Genetic Profiling in Adult T-Cell Leukemia/Lymphoma
2015 · Keisuke Kataoka, Yasunobu Nagata, et al. · Blood · 3
Loss‐Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic Anemia
2025 · Yoshitaka Zaimoku, Hirohito Yamazaki, et al. · American Journal of Hematology · 2
[Japanese patient preferences between ravulizumab and eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria].
2023 · Ken Ishiyama, Kensuke Usuki, et al. · PubMed · 1
Clinical Significance of a Miniscule GPI(-) Granulocyte Population in Patients with Bone Marrow Failure
2022 · Dung Cao Tran, Kohei Hosokawa, et al. · Blood
P466: Amplified Epor/jak2 Genes Define a Unique Subtype of Acute Erythroid Leukemia
2022 · J. Takeda, K. Yoshida, et al. · HemaSphere
Erratum to: Cord blood transplantation using minimum conditioning regimens for patients with hematologic malignancies complicated by severe infections
2009 · Takeshi Yamashita, Chiharu Sugimori, et al. · International Journal of Hematology
PDF
Works count: 9
Citation count: 127
H-index: 3
I10-index: 2
Year
Topic
Type